MICROEMULSION USED AS CARRIER FOR ADMINISTRATION OF ACTIVE COMPOUNDS AND METHOD OF ITS PREPARING Russian patent published in 2001 - IPC

Abstract RU 2164134 C2

FIELD: medicine, pharmacy. SUBSTANCE: invention proposes nontoxic microemulsion of type "oil-in-water" or bioconstant microemulsion consisting of polar phase, nonpolar phase and a mixture of hydrophilic and hydrophobic surface active substance. Polar phase has water and one or more components regulating its polarity properties. Nonpolar phase consists of one or more pharmaceutically acceptable oil. Amount of surface-active substance mixture is up to 15% of emulsion mass. Hydrophobic surface-active substance is taken among the group: lecithin, sphingolipids and galactolipids. Microemulsion is prepared by mixing components in any sequence. Mixture is kept to stand for one or two days up to equilibrium state. Equilibrium can be accelerated by the mold mixture heating at 40 C and stirring or shaking in regular time intervals. Invention can be used for remedy preparation making. EFFECT: minimal amount of surface-active substance used, decreased toxicity of preparations based on microemulsion claimed. 23 cl, 1 dwg, 4 tbl, 4 ex

Similar patents RU2164134C2

Title Year Author Number
DERIVATIVES OF 1,1-BIS(HETEROAZOLYL)ALKANES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT USING THESE COMPOUNDS 1995
  • Bernard Robin Bor
  • Dankan Ehlester Grej
  • Dennis Mark O'Shi
RU2155763C2
MICROEMULSION COMPOSITIONS 2019
  • Solfato, Elena
  • Abbate, Ilenia
  • Zappulla, Cristina Maria Concetta
  • Santonocito, Manuela
  • Viola, Santa
  • De Falco, Sandro
  • Giuliano, Francesco
RU2787998C1
S-ENANTIOMER OF SUBSTITUTED 2-AMINOTETRALINE, METHODS OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING PROPERTY OF 5- RECEPTOR ANTAGONIST 1990
  • Uli Khaksell[Se]
  • Sven-Ehrik Khillver[Se]
RU2086537C1
PHARMACEUTICAL EMULSION COMPOSITION, METHOD OF ITS PREPARING AND METHOD OF BLOOD PRESSURE DECREASE 1994
  • Chell' Jal'Mar Andersson
  • Ehva Kristina Bjured
  • Anna-Karin Khansson
  • Margareta Nordlander
  • Rol'F Krister Vesterlund
RU2144358C1
NOVEL SALT 1998
  • Njukvist Khokan
  • Son Dehniehl D.
RU2193560C2
DERIVATIVES OF (1-PHENYL-1-HETEROCYCLYL)ALKANE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL PREPARATION SHOWING NEUROPROTECTIVE EFFECT IN BRAIN ISCHEMIA, METHOD OF TREATMENT OF PATIENTS WITH HYPOXIC AND ASPHYXIC BRAIN DAMAGES 1994
  • Bernard Robin Bor
  • Alan Dzhon Kross
  • Dunkan Ehlester Grej
  • Alfred Richard Grin
RU2137763C1
METHYLISOPROPYL-[(3-N-PROPOXYPHENOXY)ETHYL]AMINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHODS OF ITS SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD OF TOPICAL ANESTHESIA 1996
  • Sandberg Rune
RU2193555C2
NOVEL COMPOUNDS 1997
  • Amin Kosrat
  • Dakhl'Strem Mikaehl'
  • Nordberg Peter
  • Starke Ingemar
RU2184113C2
OPTICALLY PURE Na, Mg, Li, K OR Ca SALTS OF (-)-5-METHOXY-2-[[(4- -METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL]SULFINYL]-1H-BENZ-IMIDAZOLE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON SAID AND INTERMEDIATE COMPOUND 1994
  • Per Lennart Lindberg
  • Sverker Von Unge
RU2137766C1
ADVANCED DRUG DELIVERY SYSTEM 2004
  • Charman Uill'Jam
  • Dias Monika
  • Zhorzhiu Mishell'
  • Gaffogg Filip
  • Porter Kristofer
  • Pauton Kolin
  • Stil Frehjzer
  • Uiler Derek
RU2353350C2

RU 2 164 134 C2

Authors

Von Korsvant Kristian

Dates

2001-03-20Published

1996-09-04Filed